CN111450133A - An unguent for the treatment of lumbar intervertebral disc prolapse, hyperosteogeny, and cervical spondylosis - Google Patents

An unguent for the treatment of lumbar intervertebral disc prolapse, hyperosteogeny, and cervical spondylosis Download PDF

Info

Publication number
CN111450133A
CN111450133A CN202010389362.XA CN202010389362A CN111450133A CN 111450133 A CN111450133 A CN 111450133A CN 202010389362 A CN202010389362 A CN 202010389362A CN 111450133 A CN111450133 A CN 111450133A
Authority
CN
China
Prior art keywords
ointment
powder
hyperosteogeny
cervical spondylosis
poria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010389362.XA
Other languages
Chinese (zh)
Inventor
李守彦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010389362.XA priority Critical patent/CN111450133A/en
Publication of CN111450133A publication Critical patent/CN111450133A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses an ointment for treating lumbar disc herniation, hyperosteogeny and cervical spondylosis, which comprises the following components: notoginseng, dahurian angelica root, poria and salvia leaf. The invention also discloses a preparation method and a use method of the ointment for treating lumbar disc herniation, hyperosteogeny and cervical spondylosis. The traditional Chinese medicine is prepared from pure traditional Chinese medicines, has no toxic or side effect, does not need to bear any operation risk, directly acts on an affected part, is beneficial to absorption by a human body, has short treatment period, and causes no pain and no relapse after use; and the formula is simple, the cost is low, and the use is convenient.

Description

An unguent for the treatment of lumbar intervertebral disc prolapse, hyperosteogeny, and cervical spondylosis
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to an ointment for treating lumbar disc herniation, hyperosteogeny and cervical spondylosis.
Background
For the diseases such as lumbar disc herniation, hyperosteogeny, cervical spondylosis and the like, the domestic treatment means are conservative, and the defects of slow effect and incomplete treatment exist if the Chinese medicaments are taken, traction, massage, acupuncture and moxibustion, closure and the like; the limited surgery mainly comprises two types of percutaneous puncture nucleotomy and collagenase chemical solution, the early treatment effect is quick, but not all patients are suitable, the indication is less, and the surgical treatment is accompanied by certain damage and risk and paralyzes the people; the foreign treatment adopts the hybrid laser therapy, but the treatment cost is high for going out of country, the time cost is high, and the common people cannot bear the treatment cost.
Disclosure of Invention
The invention aims to provide an ointment for treating lumbar disc herniation, hyperosteogeny and cervical spondylosis, which aims to solve the problems in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme: an ointment for treating lumbar disc herniation, hyperosteogeny and cervical spondylosis is technically characterized in that: the composition consists of the following components: notoginseng, dahurian angelica root, poria and salvia leaf.
Preferably, the composition comprises the following components in parts by mass: 3-10 parts of pseudo-ginseng, 3-10 parts of angelica dahurica, 5-10 parts of poria cocos and 1-5 parts of erysipelas leaves.
Preferably, the ointment is prepared by the following steps:
s1: pretreatment of pseudo-ginseng: drying Notoginseng radix in the air, oven drying in microwave oven, taking out, and pulverizing into powder with pulverizer to obtain Notoginseng radix powder;
s2: preprocessing radix angelicae: soaking radix Angelicae Dahuricae in water for half an hour, taking out, oven drying, removing water, and pulverizing into powder to obtain radix Angelicae Dahuricae powder;
s3: pretreating poria cocos: soaking Poria in water for half an hour, taking out, oven drying, removing water, and pulverizing into powder to obtain Poria powder;
s4: uniformly mixing: mixing Notoginseng radix powder, radix Angelicae Dahuricae powder and Poria powder, and sieving to obtain total medicinal powder;
s5: pretreatment of the Plumbum preparatium leaves: cleaning the Plumbum preparatium leaves with clear water, putting into a container, and smashing into paste to obtain Plumbum preparatium leaf slurry for later use;
s6: blending: mixing the total medicinal powder and the slurry, stirring to obtain viscous paste, and making into ointment.
Preferably, the sieving is performed by a 100-200 mesh sieve.
Preferably, the application method of the ointment comprises the following steps: the ointment is applied to the affected part, and a waterproof medical adhesive plaster is attached, and the ointment is replaced every 24 h.
Preferably, the ointment is applied to a thickness of not less than 5 mm.
Compared with the prior art, the traditional Chinese medicine is prepared from pure traditional Chinese medicines, has no toxic or side effect, does not need to bear any operation risk, directly acts on an affected part, is beneficial to absorption by a human body, has short treatment period, and causes no recurrence of pain after use; and the formula is simple, the cost is low, and the use is convenient.
Detailed Description
The invention is further illustrated by the following examples, without limiting the scope of the invention.
Example 1
The invention provides a technical scheme, and an ointment for treating lumbar disc herniation, hyperosteogeny and cervical spondylosis comprises the following components: notoginseng, dahurian angelica root, poria and salvia leaf.
In the embodiment, the coating comprises the following components in parts by mass: 3 parts of pseudo-ginseng, 3 parts of angelica dahurica, 5 parts of poria cocos and 1 part of erysipelas leaves.
In the embodiment, the preparation steps of the ointment are as follows:
s1: pretreatment of pseudo-ginseng: drying Notoginseng radix in the air, oven drying in microwave oven, taking out, and pulverizing into powder with pulverizer to obtain Notoginseng radix powder;
s2: preprocessing radix angelicae: soaking radix Angelicae Dahuricae in water for half an hour, taking out, oven drying, removing water, and pulverizing into powder to obtain radix Angelicae Dahuricae powder;
s3: pretreating poria cocos: soaking Poria in water for half an hour, taking out, oven drying, removing water, and pulverizing into powder to obtain Poria powder;
s4: uniformly mixing: mixing Notoginseng radix powder, radix Angelicae Dahuricae powder and Poria powder, and sieving to obtain total medicinal powder;
s5: pretreatment of the Plumbum preparatium leaves: cleaning the Plumbum preparatium leaves with clear water, putting into a container, and smashing into paste to obtain Plumbum preparatium leaf slurry for later use;
s6: blending: mixing the total medicinal powder and the slurry, stirring to obtain viscous paste, and making into ointment.
In the present embodiment, the screening is performed by using a 100-mesh screen.
In the embodiment, the application method of the ointment comprises the following steps: the ointment is applied to the affected part, and a waterproof medical adhesive plaster is attached, and the ointment is replaced every 24 h.
In the embodiment, the coating thickness of the ointment is not less than 5 mm.
Example 2
The invention provides a technical scheme, and an ointment for treating lumbar disc herniation, hyperosteogeny and cervical spondylosis comprises the following components: notoginseng, dahurian angelica root, poria and salvia leaf.
In the embodiment, the coating comprises the following components in parts by mass: 10 parts of pseudo-ginseng, 10 parts of angelica dahurica, 10 parts of poria cocos and 5 parts of erysipelas leaves.
In the embodiment, the preparation steps of the ointment are as follows:
s1: pretreatment of pseudo-ginseng: drying Notoginseng radix in the air, oven drying in microwave oven, taking out, and pulverizing into powder with pulverizer to obtain Notoginseng radix powder;
s2: preprocessing radix angelicae: soaking radix Angelicae Dahuricae in water for half an hour, taking out, oven drying, removing water, and pulverizing into powder to obtain radix Angelicae Dahuricae powder;
s3: pretreating poria cocos: soaking Poria in water for half an hour, taking out, oven drying, removing water, and pulverizing into powder to obtain Poria powder;
s4: uniformly mixing: mixing Notoginseng radix powder, radix Angelicae Dahuricae powder and Poria powder, and sieving to obtain total medicinal powder;
s5: pretreatment of the Plumbum preparatium leaves: cleaning the Plumbum preparatium leaves with clear water, putting into a container, and smashing into paste to obtain Plumbum preparatium leaf slurry for later use;
s6: blending: mixing the total medicinal powder and the slurry, stirring to obtain viscous paste, and making into ointment.
In the embodiment, the sieving is performed by a 200-mesh sieve.
In the embodiment, the application method of the ointment comprises the following steps: the ointment is applied to the affected part, and a waterproof medical adhesive plaster is attached, and the ointment is replaced every 24 h.
In the embodiment, the coating thickness of the ointment is not less than 5 mm.
Example 3
The invention provides a technical scheme, and an ointment for treating lumbar disc herniation, hyperosteogeny and cervical spondylosis comprises the following components: notoginseng, dahurian angelica root, poria and salvia leaf.
In the embodiment, the coating comprises the following components in parts by mass: 5 parts of pseudo-ginseng, 6 parts of angelica dahurica, 7 parts of poria cocos and 3 parts of erysipelas leaves.
In the embodiment, the preparation steps of the ointment are as follows:
s1: pretreatment of pseudo-ginseng: drying Notoginseng radix in the air, oven drying in microwave oven, taking out, and pulverizing into powder with pulverizer to obtain Notoginseng radix powder;
s2: preprocessing radix angelicae: soaking radix Angelicae Dahuricae in water for half an hour, taking out, oven drying, removing water, and pulverizing into powder to obtain radix Angelicae Dahuricae powder;
s3: pretreating poria cocos: soaking Poria in water for half an hour, taking out, oven drying, removing water, and pulverizing into powder to obtain Poria powder;
s4: uniformly mixing: mixing Notoginseng radix powder, radix Angelicae Dahuricae powder and Poria powder, and sieving to obtain total medicinal powder;
s5: pretreatment of the Plumbum preparatium leaves: cleaning the Plumbum preparatium leaves with clear water, putting into a container, and smashing into paste to obtain Plumbum preparatium leaf slurry for later use;
s6: blending: mixing the total medicinal powder and the slurry, stirring to obtain viscous paste, and making into ointment.
In the embodiment, the screening is performed by using a 180-mesh screen.
In the embodiment, the application method of the ointment comprises the following steps: the ointment is applied to the affected part, and a waterproof medical adhesive plaster is attached, and the ointment is replaced every 24 h.
In the embodiment, the coating thickness of the ointment is not less than 5 mm.
Note that: during the repair period when the ointment is used
1. It is contraindicated for patients with skin allergy, heart support, cardiovascular and cerebrovascular diseases, lactation, menstrual period, and other comprehensive diseases.
2. During the treatment period, the wound is free from inflammation, infection and tetanus, and the curative effect can be influenced because the anti-inflammatory, the analgesic and the antibiotic medicines can not be taken at the same time.
3. For example, the itching is caused by pasting the rheumatism ointment around the wound, the rheumatism ointment is cut into half pieces, only the wound is pasted, the dermatitis ointment is smeared around the wound, and other allergic itching-relieving ointments are formed.
4. Diet and dietetic restraint: sour and hot wine.
Case 1: for all women, the 54 th year old, the waist 3/4 has obvious limitation on intervertebral discs, the waist and the left lower limb have pain, the person stands for about 5 minutes, the waist is not strong, the legs cannot support the person to stand continuously, the person walks for about half a minute, the pain is hard to endure, and the person only needs to lie in bed for rest. The formula can be applied to the waist for 3 days, and can be moved out of bed. After 45 days of treatment, people can normally go to work and live. No relapse occurs in 2 years.
Case 2: jia a, male, age 30, programmer, cervical pain, dizziness, with nausea and vomiting symptoms, left arm tingling. The formula is applied to the cervical vertebra to treat for 7 days, sensory symptoms become light, after 30 days of treatment, the symptoms disappear completely, and the life of a patient is normal. No recurrence was observed in 3 years.
Case 3: chua is a certain male, aged 57 years old, waist hyperosteogeny, pain in waist and right leg are difficult to endure, normal walking cannot be performed, sleep cannot be performed at night, and people can only sit and lie in bed. The formula is applied to the cervical vertebra to treat 7 days, can fall asleep at night, can move properly in the daytime, and can relieve the pain of the waist after 20 days of treatment and relieve the pain of the legs after 45 days of treatment to recover normal life. No recurrence occurred in 5 years.
The invention has the following characteristics:
1. the time for discharging pus and toxic tissue fluid is 10 to 15 days without undrawn pus, and the pus and the toxic tissue fluid are thoroughly cleared to eliminate pathogens;
2. the non-infectious shape can pass through pores and reach the injured part, and the pore channels are used for drawing out the deposited toxin;
3. the moxibustion is repeatedly applied to the same affected part, and the problem is solved at one time;
4. has little pain and does not affect work and life.
The traditional moxibustion fire suppuration moxibustion and foaming moxibustion are improved to cause difficult treatment process of pain of human body, the limited disease treatment range of the moxibustion fire is expanded, the traditional Chinese medicine is forbidden to use fire moxibustion when distinguishing damp syndromes, dampness and fire easily generate phlegm, dampness and heat are equal to fire-watered oil, heart is subjected to fire moxibustion and heartbeat is accelerated, the traditional Chinese medicine has the defects of yin moxibustion, suppuration moxibustion and abandon fire moxibustion, herbal medicines are used for infusing non-fire and non-heat moxibustion, the moxibustion is suitable for treating diseases and repairing the range of pain, the moxibustion can be applied for treating diseases and distinguishing symptoms, the mechanism of human body life balance regulation is originally formed, the natural moxibustion has the effect of damp yang diuresis and the suppuration moxibustion can clear out evil and clear out all turbid pathogenic factors which can not be passed through by the damp yang qi of the yellow emperor the yin-formed body, and the suppuration moxibustion theory of the natural moxibustion is a therapy which can support yang qi and clear away all turbid pathogenic factors which can not pass through the damp.
The moxibustion therapy and repair of tens of thousands of patients with osteoarthropathy do not have the effects of repairing the same affected part by repeatedly applying moxibustion to the affected part and independently showing pus, the use range of the moxibustion therapy is satisfied, the theory that injured periosteum such as articular vertebra and the like is reduced and inflammation is reduced by occupational diseases and degenerative diseases is corrected by applying moxibustion to the affected part, the pathology that the bone qi is not communicated is maintained, the communication is not painful, such as intervertebral disc swelling disease, dampness-retention disease is mild and more water, water accumulation is more and swelling is protruded, the severe patients get rid of the hyperosteogeny and the like, the bone qi is excessive cold and the excessive cold qi cannot be communicated, the developed bone spur and sciatica are more bladder channel defects, the dampness syndrome and scapulohumeral periarthritis are caused by invasion of cold evil, the scapularthritis is caused by injury and siltation of peripheral nerves of scapula, other tumors caused by blockage, the unknown tumors, mastitis and the like are formed by turbid retention and blockage, the direct moxibustion therapy is directly applied, the pathogenic factor of drilling and standing, and the toxin is seen in vitro, the injury disease caused by yang qi rising dampness evil and promoting qi and blood circulation can be cured by eliminating the one-time cleavage disease.
The traditional Chinese medicine is prepared from pure traditional Chinese medicines, has no toxic or side effect, does not need to bear any operation risk, directly acts on an affected part, is beneficial to absorption by a human body, has short treatment period, and causes no pain and no relapse after use; and the formula is simple, the cost is low, and the use is convenient.
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein, and any reference thereto is therefore intended to be embraced therein.
Furthermore, it should be understood that although the present description refers to embodiments, not every embodiment may contain only a single embodiment, and such description is for clarity only, and those skilled in the art should integrate the description, and the embodiments may be combined as appropriate to form other embodiments understood by those skilled in the art.

Claims (6)

1. An ointment for treating lumbar disc herniation, hyperosteogeny and cervical spondylosis is characterized by comprising the following components: notoginseng, dahurian angelica root, poria and salvia leaf.
2. The ointment for treating lumbar disc herniation, hyperosteogeny and cervical spondylosis as claimed in claim 1, is characterized in that: the composition comprises the following components in parts by mass: 3-10 parts of pseudo-ginseng, 3-10 parts of angelica dahurica, 5-10 parts of poria cocos and 1-5 parts of erysipelas leaves.
3. The ointment for treating lumbar disc herniation, hyperosteogeny and cervical spondylosis as claimed in claim 1, is characterized in that: the preparation steps of the ointment are as follows:
s1: pretreatment of pseudo-ginseng: drying Notoginseng radix in the air, oven drying in microwave oven, taking out, and pulverizing into powder with pulverizer to obtain Notoginseng radix powder;
s2: preprocessing radix angelicae: soaking radix Angelicae Dahuricae in water for half an hour, taking out, oven drying, removing water, and pulverizing into powder to obtain radix Angelicae Dahuricae powder;
s3: pretreating poria cocos: soaking Poria in water for half an hour, taking out, oven drying, removing water, and pulverizing into powder to obtain Poria powder;
s4: uniformly mixing: mixing Notoginseng radix powder, radix Angelicae Dahuricae powder and Poria powder, and sieving to obtain total medicinal powder;
s5: pretreatment of the Plumbum preparatium leaves: cleaning the Plumbum preparatium leaves with clear water, putting into a container, and smashing into paste to obtain Plumbum preparatium leaf slurry for later use;
s6: blending: mixing the total medicinal powder and the slurry, stirring to obtain viscous paste, and making into ointment.
4. The ointment for treating lumbar disc herniation, hyperosteogeny and cervical spondylosis as claimed in claim 3, is characterized in that: the sieving is performed by using a 100-200-mesh sieve.
5. The ointment for treating lumbar disc herniation, hyperosteogeny and cervical spondylosis as claimed in claim 1, is characterized in that: the application method of the ointment comprises the following steps: the ointment is applied to the affected part, and a waterproof medical adhesive plaster is attached, and the ointment is replaced every 24 h.
6. The ointment for treating lumbar disc herniation, hyperosteogeny and cervical spondylosis as claimed in claim 6, is characterized in that: the coating thickness of the ointment is not less than 5 mm.
CN202010389362.XA 2020-05-10 2020-05-10 An unguent for the treatment of lumbar intervertebral disc prolapse, hyperosteogeny, and cervical spondylosis Pending CN111450133A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010389362.XA CN111450133A (en) 2020-05-10 2020-05-10 An unguent for the treatment of lumbar intervertebral disc prolapse, hyperosteogeny, and cervical spondylosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010389362.XA CN111450133A (en) 2020-05-10 2020-05-10 An unguent for the treatment of lumbar intervertebral disc prolapse, hyperosteogeny, and cervical spondylosis

Publications (1)

Publication Number Publication Date
CN111450133A true CN111450133A (en) 2020-07-28

Family

ID=71671154

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010389362.XA Pending CN111450133A (en) 2020-05-10 2020-05-10 An unguent for the treatment of lumbar intervertebral disc prolapse, hyperosteogeny, and cervical spondylosis

Country Status (1)

Country Link
CN (1) CN111450133A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109091652A (en) * 2018-10-15 2018-12-28 刘斌 A kind of externally applied Chinese medicine for treating prolapse of lumbar intervertebral disc cervical spondylosis osteoproliferation arthritis tenosynovitis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109091652A (en) * 2018-10-15 2018-12-28 刘斌 A kind of externally applied Chinese medicine for treating prolapse of lumbar intervertebral disc cervical spondylosis osteoproliferation arthritis tenosynovitis

Similar Documents

Publication Publication Date Title
CN107050118B (en) Traditional Chinese medicine plaster for treating wind-cold-dampness arthralgia and preparation method thereof
CN101905011A (en) Chinese medicinal composition for treating cervical spondylosis
CN115737704B (en) She mud moxibustion composition for relaxing tendons and activating collaterals
CN110743000A (en) Traditional Chinese medicine composition for acupoint application wet application and preparation method and using method thereof
CN1205887A (en) Pain relieving ointment
CN111450133A (en) An unguent for the treatment of lumbar intervertebral disc prolapse, hyperosteogeny, and cervical spondylosis
CN109223866A (en) A kind of wormwood powder for dipping feet and preparation method thereof
CN108066572B (en) Plaster for treating gonarthromeningitis and preparation method thereof
CN115227678A (en) A Chinese medicinal patch for treating hyperosteogeny and bony spur
CN104623617B (en) Medicine for treating osteoarticular diseases and preparation method and using method thereof
CN110101832B (en) Machilus thunbergii traditional Chinese medicine composition and preparation method thereof
CN112138047A (en) Traditional Chinese medicine composition with functions of warming yang and tonifying kidney, traditional Chinese medicine plaster and preparation method thereof
CN1267127C (en) Osteoproliferation medicine for external application
CN111358915A (en) Traditional Chinese medicine for treating congenital muscular torticollis and preparation method thereof
CN104971286A (en) Traditional Chinese medicine composition for treating shoulder, waist and leg discomfort
CN104491700A (en) Externally-applied traditional Chinese medicine for treating rheumatism nervous arthralgia and preparation method of externally-applied traditional Chinese medicine
CN110279746A (en) A kind of massage cream and preparation method thereof for treating traumatic injury
CN109806351A (en) Neck-shoulder pain, lumbago and leg pain temperature, which is applied, to be dissipated
CN108578539A (en) A kind of hot compress agent of cure scapulohumeral periarthritis cervical spondylosis and its hot compress method
CN107714843A (en) A kind of orthopedics external-use plaster
CN108686146A (en) A kind of Dressed plaster promoting blood circulation and removing blood stasis and preparation method thereof
CN115554356B (en) Traditional Chinese medicine composition, plaster containing traditional Chinese medicine composition and preparation method of plaster
CN117357608B (en) External application medicine for treating traumatic injury and fracture and tendon injury
CN102343081A (en) Moxibustion tool of pure Chinese medicinal preparation for treating bone aching and pure Chinese medicinal preparation for treating bone aching
CN107929696B (en) External traditional Chinese medicine composition for relieving swelling, relaxing muscles and setting bones as well as preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200728